By Alexis Reyes On Saturday, August 17th, Milwaukee County Executive David Crowley, and Congresswoman (D-VA) Jennifer McClellan hosted a roundtable for local community members to share their experiences regarding medical coverage and the impact that presidential nominee, Vice President Kamala Harris will have on the future of medical costs. The roundtable also addressed the concerning […]
Biden and Harris Reunite to Highlight Drug Pricing Deal
By Karen Stokes On Thursday, President Joe Biden and Vice President Kamala Harris appeared together for the first time since Biden withdrew from the presidential race. They focused on fulfilling their commitment to reducing out-of-pocket drug costs for seniors and saving money for Americans. The Inflation Reduction Act enabled Medicare to be able to negotiate […]
Congress Listens, Avoids Damaging Prescription Drug Market
By Milwaukee Courier Staff MILWAUKEE – Imagine having prescription drug prices rise by double digits after all the inflation Americans already have experienced regarding food, housing, automobiles, gasoline, clothing, and so much more over the past two years. That was just the concern a multicultural coalition of small business owners from across Wisconsin had when […]
Biden Harris Administration on Process to Lower Prescription Drug Costs
By Karen Stokes Today, the Biden-Harris Administration announced a major development they’re taking to negotiate for and lower the cost of several common prescription drugs. “It’s important to recognize that never before in the history of our country has a Medicare program which covers 65 million Americans, mostly seniors and Americans with disabilities. They have […]
Biden-Harris Administration Takes Sweeping Actions to Lower Healthcare Costs
The Biden-Harris Administration has unveiled a comprehensive plan to ensure accessible, affordable healthcare for all Americans.
Seniors Across the Country Are Saving Millions of Dollars in Health Care Costs
By Karen Stokes On Wednesday, President Biden was in Las Vegas discussing how his prescription drug law is lowering health care costs and prescription drug prices for seniors across the country. Americans pay two to three times more for prescription drugs than citizens in other countries and the President and Congressional Democrats took on special […]
Eli Lilly Heeds President Joe Biden’s Call to Cap the Price of Insulin
By Karen Stokes As part of President Biden’s Inflation Reduction Act, nearly four million seniors on Medicare with diabetes started to see their insulin costs capped at $35 per month this past January, saving some seniors hundreds of dollars for a month’s supply. President Biden made clear in his State of the Union address that […]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
To Help Patients Save Money, Congress Needs to Tackle the Middlemen in Health Care
By Sally C. Pipes As a Republican-controlled House of Representatives with a small majority opens for business in January, one member has especially big ideas for saving patients money on prescription drug costs — and the research to back it up. A year ago, Rep. James Comer (R-KY) released a comprehensive report on the role […]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
340B Doesn’t Solve Health Inequities
By Amy Hinojosa Advocates have long fought for federal funding to reach people in most need. Back in 1992, Congress established the 340B drug pricing program, which guaranteed drug discounts to hospitals serving a disproportionately high percentage of uninsured or low-income patients. Congress hoped the legislation would help hospitals provide better, less expensive care. But […]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
“March In” Is Not the Answer
By Howard Dean All Democrats and many Republicans are committed to making prescription drugs more affordable. There is one strategy that is likely to make things worse: overriding patents on drugs developed with the help of federally funded research. This “march-in” option is not a good idea. It hinges on the Bayh-Dole Act, a 40-year-old […]